NVS Novartis AG Earnings and EPS analysis

EPS in 2025 (TTM): $6.44

Last Report Period Date: Mar 31, 2025

As of June 2025, according to Novartis AG's latest financial report, the company's current EPS (TTM) is $6.44. In 2024, the company recorded an earnings per share (EPS) of $5.92, which represents a decrease compared to its EPS of $7.15 in 2023. Novartis AG's earnings per share for the quarterly report ending on Mar 31, 2025 was $1.83.

The annual EPS in 2024 was $5.92, a decrease of 17.2% from $7.15 in 2023. For the quarter ending Mar 31, 2025, the EPS was $1.83, showing a 39.7% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2025 is $6.44. In 2023, the annual EPS was $7.15, showing an increase of 124.1% from 2022.

Over the last 12 months, Novartis AG has registered an EPS growth of 39.7% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of -17.9% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 2.9%. A 10-year view shows that NVS has seen an average EPS growth of 3.5% per year.